Market News

West Pharmaceutical Svsc (WST) Holder Southeast Asset Advisors Has Decreased Stake by $664,440; General Electric Co (GE) Holder Boyar Asset Management Has Trimmed Stake as Market Valuation Declined

West Pharmaceutical Services, Inc. (NYSE:WST) Logo

Boyar Asset Management Inc decreased its stake in General Electric Co (GE) by 73.04% based on its latest 2017Q4 regulatory filing with the SEC. Boyar Asset Management Inc sold 59,245 shares as the company’s stock declined 23.20% with the market. The hedge fund held 21,869 shares of the consumer electronics and appliances company at the end of 2017Q4, valued at $382,000, down from 81,114 at the end of the previous reported quarter. Boyar Asset Management Inc who had been investing in General Electric Co for a number of months, seems to be less bullish one the $131.15 billion market cap company. The stock increased 2.65% or $0.39 during the last trading session, reaching $15.1. About 35.17M shares traded. General Electric Company (NYSE:GE) has declined 54.35% since May 16, 2017 and is downtrending. It has underperformed by 65.90% the S&P500.

Southeast Asset Advisors Inc decreased its stake in West Pharmaceutical Svsc Inc (WST) by 40.76% based on its latest 2017Q4 regulatory filing with the SEC. Southeast Asset Advisors Inc sold 6,780 shares as the company’s stock declined 13.33% with the market. The institutional investor held 9,855 shares of the basic industries company at the end of 2017Q4, valued at $972,000, down from 16,635 at the end of the previous reported quarter. Southeast Asset Advisors Inc who had been investing in West Pharmaceutical Svsc Inc for a number of months, seems to be less bullish one the $6.56B market cap company. The stock decreased 0.02% or $0.02 during the last trading session, reaching $89.18. About 139,758 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 6.37% since May 16, 2017 and is uptrending. It has underperformed by 5.18% the S&P500.

Southeast Asset Advisors Inc, which manages about $1.76B and $330.49M US Long portfolio, upped its stake in Centurylink Inc (NYSE:CTL) by 763,307 shares to 774,780 shares, valued at $12.92 million in 2017Q4, according to the filing. It also increased its holding in Gartner Inc (NYSE:IT) by 3,567 shares in the quarter, for a total of 21,761 shares, and has risen its stake in Berkshire Hathaway Inc Del (BRKB).

Since December 8, 2017, it had 0 insider purchases, and 2 insider sales for $6.61 million activity.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. West Pharmaceutical Services had 16 analyst reports since August 4, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Tuesday, June 6. Jefferies upgraded West Pharmaceutical Services, Inc. (NYSE:WST) on Friday, September 15 to “Buy” rating. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) earned “Hold” rating by Jefferies on Thursday, June 29. The rating was downgraded by Bank of America to “Sell” on Wednesday, April 25. The firm earned “Hold” rating on Tuesday, October 17 by Bank of America. The rating was maintained by Jefferies on Thursday, February 15 with “Buy”. The company was initiated on Tuesday, March 22 by Wells Fargo. The rating was maintained by Jefferies on Thursday, July 27 with “Hold”. The company was maintained on Monday, September 11 by Jefferies. On Friday, October 28 the stock rating was upgraded by Wells Fargo to “Outperform”.

Another recent and important West Pharmaceutical Services, Inc. (NYSE:WST) news was published by Seekingalpha.com which published an article titled: “West Pharmaceutical Services’ (WST) CEO Eric Green on Q1 2018 Results – Earnings Call Transcript” on April 26, 2018.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on July, 26. They expect $0.66 earnings per share, up 29.41% or $0.15 from last year’s $0.51 per share. WST’s profit will be $48.56M for 33.78 P/E if the $0.66 EPS becomes a reality. After $0.62 actual earnings per share reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts 6.45% EPS growth.

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.16, from 1.33 in 2017Q3. It dived, as 19 investors sold WST shares while 97 reduced holdings. 48 funds opened positions while 88 raised stakes. 67.16 million shares or 1.36% less from 68.09 million shares in 2017Q3 were reported. Eaton Vance Mngmt holds 0.07% or 288,231 shares in its portfolio. Tower Rech Capital Ltd (Trc) reported 90 shares. Weaver C Barksdale And Associate Incorporated invested in 88 shares. Ngam Advisors Limited Partnership stated it has 0.01% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST). Alps Advsrs reported 2,088 shares stake. Jefferies Grp Inc Limited Liability reported 13,022 shares stake. Westpac Bk stated it has 0.11% in West Pharmaceutical Services, Inc. (NYSE:WST). Bridgecreek Inv Mgmt Ltd reported 3,000 shares stake. Earnest Prtn Lc owns 0% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 20 shares. Prudential Finance, a New Jersey-based fund reported 66,226 shares. 9,050 were reported by Balyasny Asset Ltd Llc. Tiaa Cref Invest Mngmt Ltd Com owns 126,132 shares. Fil Limited reported 0.03% stake. 939,351 were accumulated by Hermes Inv Mgmt Ltd. Rmb Cap Mngmt, Illinois-based fund reported 130,050 shares.

Investors sentiment decreased to 0.5 in 2017 Q4. Its down 0.19, from 0.69 in 2017Q3. It worsened, as 153 investors sold GE shares while 921 reduced holdings. 151 funds opened positions while 383 raised stakes. 4.69 billion shares or 0.29% less from 4.70 billion shares in 2017Q3 were reported. Stone Ridge Asset Management Limited Liability Co has invested 0.03% in General Electric Company (NYSE:GE). Westwood Hldgs Grp reported 0% stake. Ironwood Invest Counsel Ltd Company holds 3.04% or 471,847 shares. Crestpoint Capital Mngmt Limited Liability Company has invested 0.14% in General Electric Company (NYSE:GE). Mason Street Lc has invested 0.49% in General Electric Company (NYSE:GE). Cheviot Value Mgmt Ltd Limited Liability Company has invested 1.3% in General Electric Company (NYSE:GE). Schwartz Counsel has invested 0.02% of its portfolio in General Electric Company (NYSE:GE). Moreover, New Vernon Invest Ltd Liability Corporation has 0.29% invested in General Electric Company (NYSE:GE) for 16,183 shares. Investment Counsel holds 142,344 shares or 1.03% of its portfolio. Harvey Ltd Llc holds 0.54% of its portfolio in General Electric Company (NYSE:GE) for 171,058 shares. Stratos Wealth Partners reported 0.2% in General Electric Company (NYSE:GE). Jump Trading Limited Liability Company reported 56,051 shares. Tegean Mgmt Limited Liability Corporation stated it has 300,000 shares. 32,388 were reported by Lakeview Capital Ptnrs Lc. Lazard Asset Mgmt Limited Liability Co has 5.36M shares for 0.18% of their portfolio.

Analysts await General Electric Company (NYSE:GE) to report earnings on July, 20. They expect $0.18 EPS, down 35.71% or $0.10 from last year’s $0.28 per share. GE’s profit will be $1.56 billion for 20.97 P/E if the $0.18 EPS becomes a reality. After $0.16 actual EPS reported by General Electric Company for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

Among 29 analysts covering General Electric Company (NYSE:GE), 9 have Buy rating, 6 Sell and 14 Hold. Therefore 31% are positive. General Electric Company had 102 analyst reports since July 21, 2015 according to SRatingsIntel. As per Monday, June 12, the company rating was maintained by Oppenheimer. As per Wednesday, October 14, the company rating was maintained by Stifel Nicolaus. maintained General Electric Company (NYSE:GE) on Monday, October 10 with “Buy” rating. The firm has “Hold” rating given on Sunday, December 10 by Stifel Nicolaus. The rating was maintained by Citigroup with “Buy” on Monday, October 23. As per Monday, November 30, the company rating was maintained by RBC Capital Markets. CFRA downgraded the shares of GE in report on Friday, July 21 to “Hold” rating. The firm has “Outperform” rating by Bernstein given on Friday, December 16. The stock has “Neutral” rating by Bank of America on Wednesday, April 26. The stock has “Sell” rating by Deutsche Bank on Tuesday, November 21.

Since January 26, 2018, it had 1 buying transaction, and 0 insider sales for $43,446 activity.

More notable recent General Electric Company (NYSE:GE) news were published by: Businesswire.com which released: “GE Unveils Cross-Fleet Gas Turbine Capabilities That Can Increase Performance and Reliability of Other OEM Fleets” on May 16, 2018, also Benzinga.com with their article: “Analyst: Wabtech A Buy On Potential GE Synergies” published on April 23, 2018, Seekingalpha.com published: “General Electric’s Big Payout” on May 15, 2018. More interesting news about General Electric Company (NYSE:GE) were released by: Seekingalpha.com and their article: “General Electric’s Death Could Be Best For Shareholders” published on April 25, 2018 as well as Seekingalpha.com‘s news article titled: “Gabelli on GE: ‘There is a way out'” with publication date: May 14, 2018.

West Pharmaceutical Services, Inc. (NYSE:WST) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *